Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Toxicology in Vitro

• Publication date

  2006-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.TIV.2006.01.002PMID 16472967
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcriptional induction of CYP3A4 by o,p'-DDT in HepG2 cells.

  2005cited by this paper
• New symptomatic strategies in Alzheimer's disease

  2004cited by this paper
• Interplay among platelet‐activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival

  2004cited by this paper
• In Vitro Discrimination of Fluoroquinolones Toxicity on Tendon Cells: Involvement of Oxidative Stress

  2004cited by this paper
• Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells.

  2004cited by this paper
• Tacrine inhibits topoisomerases and DNA synthesis to cause mitochondrial DNA depletion and apoptosis in mouse liver

  2003cited by this paper
• Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties.

  2003cited by this paper
• Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus

  2003cited by this paper
• Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine.

  2002cited by this paper
• The metabolism and excretion of galantamine in rats, dogs, and humans.

  2002cited by this paper
• Platelet‐activating factor induces permeability transition and cytochrome c release in isolated brain mitochondria

  2002cited by this paper
• Galantamine Pharmacokinetics, Safety, and Tolerability Profiles Are Similar in Healthy Caucasian and Japanese Subjects

  2002cited by this paper
• Formation of reactive oxygen species in rat hepatoma-derived Fa32 cells to predict human toxicity.

  2002cited by this paper
• Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells

  2002cited by this paper
• Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells.

  2001cited by this paper
• Cholinesterase Inhibitors Stabilize Alzheimer's Disease

  2000cited by this paper
• Interaction between neurone and microglia mediated by platelet‐activating factor

  2000cited by this paper
• Cholinesterase Inhibitors Stabilize Alzheimer Disease

  2000cited by this paper
• Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation.

  2000cited by this paper
• Hepatotoxicity of tacrine: occurrence of membrane fluidity alterations without involvement of lipid peroxidation.

  2000cited by this paper
• Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release

  1999cited by this paper
• Tacrine-induced Reactive Oxygen Species in a Human Liver Cell Line: The Role of Anethole Dithiolethione as a Scavenger.

  1999cited by this paper
• Toxic Effects of Tacrine on Primary Hepatocytes and Liver Epithelial Cells in Culture

  1998cited by this paper
• Comparative analysis of apoptosis measured by Hoechst and flow cytometry in non-Hodgkin's lymphomas.

  1998cited by this paper
• Tacrine. A cause of fatal hepatotoxicity?

  1998cited by this paper
• Noninterference of cytochrome P4501A2 in the cytotoxicity of tacrine using genetically engineered V79 Chinese hamster cells for stable expression of the human or rat isoform and two human hepatocyte cell lines.

  1997cited by this paper
• A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability.

  1997cited by this paper
• Structure-activity relationships in platelet-activating factor (PAF). 7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity.

  1996cited by this paper
• Structure-activity relationships in platelet-activating factor (PAF). 8. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors: anti-acetylcholinesterase activity and comparative SAR.

  1996cited by this paper
• Cytotoxicity study of tacrine, structurally and pharmacologically related compounds using rat hepatocytes.

  1996cited by this paper
• Age-specific incidence of Alzheimer's disease in a community population.

  1995cited by this paper
• Quantification of mitogen induced human lymphocyte proliferation: Comparison of alamarbluetm assay to 3h‐thymidine incorporation assay

  1995cited by this paper
• A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells.

  1994cited by this paper
• Newin vitro fluorimetric microtitration assays for toxicological screening of drugs

  1994cited by this paper
• Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.

  1994cited by this paper
• Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease

  1993cited by this paper
• Features of apoptotic cells measured by flow cytometry.

  1992cited by this paper
• Platelet-activating factor-induced microvascular dysfunction: role of adherent leukocytes.

  1990cited by this paper
• Acute hepatitis after tetrahydroaminoacridine administration for Alzheimer's disease.

  1990cited by this paper
• A simple fluorometric assay for lipoperoxide in blood plasma.

  1976cited by this paper
• On the presence of the centrosome in certain nerve cells of the white rat

  1901cited by this paper

• Mechanistic exploration of dog bone-shaped tacrine analogues as telomerase inhibitors via 3D-QSAR, MD simulations, and energy landscape analysis

  2026cites this paper
• Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024

  2025cites this paper
• Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective.

  2024cites this paper
• Design, Synthesis and Bioactivity Evaluation of Coumarin–BMT Hybrids as New Acetylcholinesterase Inhibitors

  2022cites this paper
• Cytotoxic Agents in the Minor Alkaloid Groups of the Amaryllidaceae

  2021influential citation
• In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers

  2019cites this paper
• A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease.

  2017cites this paper
• AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease

  2016cites this paper
• Tacrine, an oral acetylcholinesterase inhibitor, induced hepatic oxidative damage, which was blocked by liquiritigenin through GSK3-beta inhibition.

  2015cites this paper
• Protective effect of fucosterol isolated from the edible brown algae, Ecklonia stolonifera and Eisenia bicyclis, on tert‐butyl hydroperoxide‐ and tacrine‐induced HepG2 cell injury

  2015cites this paper
• Tacrine derivatives as dual topoisomerase I and II catalytic inhibitors.

  2015cites this paper
• Tacrine induces apoptosis through lysosome- and mitochondria-dependent pathway in HepG2 cells.

  2014cites this paper
• Research Strategies Developed for the Treatment of Alzheimer’s Disease. Reversible and Pseudo-Irreversible Inhibitors of Acetylcholinesterase: Structure-Activity Relationships and Drug Design

  2014cites this paper
• Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes

  2013cites this paper
• Phellinus linteus mushroom protects against tacrine-induced mitochondrial impairment and oxidative stress in HepG2 cells.

  2013cites this paper
• Multifunctional mercapto-tacrine derivatives for treatment of age-related neurodegenerative diseases.

  2012cites this paper
• Isolation and identification of phlorotannins from Ecklonia stolonifera with antioxidant and hepatoprotective properties in tacrine-treated HepG2 cells.

  2012cites this paper
• Strategies for Inhibiting Protein Aggregation: Therapeutic Approaches to Protein-Aggregation Diseases

  2012cites this paper
• Tacrine treatment at high dose suppresses the recognition memory in juvenile and adult mice with attention to hepatotoxicity.

  2011cites this paper
• In vitro effects of acetylcholinesterase inhibitors and reactivators on Complex I of electron transport chain.

  2011cites this paper
• The PARF Antagonist AChE Inhibitor PMS777 Attenuates LPS-Induced Acute Neuroinflammation

  2011cites this paper
• Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.

  2010cites this paper
• Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment

  2009cites this paper
• Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.

  2007cites this paper
• A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine.

  2007cites this paper